Windlas Biotech, manufacturer of pharmaceutical formulations, said that it has fixed a price band of ₹448-460 per share for its ₹401-crore initial public offering (IPO). The IPO will open on August 4 and conclude on August 6. The IPO comprises fresh issuance of equity shares worth ₹165 crore and an offer for sale of up to 51,42,067 shares.